Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Firm's Unistep Wallstent enteral endoprosthesis stent gains FDA market go-ahead for duodenal and colonic indications. The device will be marketed as an alternative to colostomy before surgical removal of malignant colonic obstructions. FDA also signs off on the Unistep Plus Permalume covered biliary wallstent. The device is the first commercially available covered metal biliary stent and is indicated for treating malignant obstructions of the bile duct